Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Oct;103(4):1473-81.
doi: 10.1083/jcb.103.4.1473.

The actin filament-severing domain of plasma gelsolin

The actin filament-severing domain of plasma gelsolin

C Chaponnier et al. J Cell Biol. 1986 Oct.

Abstract

Gelsolin, a multifunctional actin-modulating protein, has two actin-binding sites which may interact cooperatively. Native gelsolin requires micromolar Ca2+ for optimal binding of actin to both sites, and for expression of its actin filament-severing function. Recent work has shown that an NH2-terminal chymotryptic 17-kD fragment of human plasma gelsolin contains one of the actin-binding sites, and that this fragment binds to and severs actin filaments weakly irrespective of whether Ca2+ is present. The other binding site is Ca2+ sensitive, and is found in a chymotryptic peptide derived from the COOH-terminal two-thirds of plasma gelsolin; this fragment does not sever F-actin or accelerate the polymerization of actin. This paper documents that larger thermolysin-derived fragments encompassing the NH2-terminal half of gelsolin sever actin filaments as effectively as native plasma gelsolin, although in a Ca2+-insensitive manner. This result indicates that the NH2-terminal half of gelsolin is the actin-severing domain. The stringent Ca2+ requirement for actin severing found in intact gelsolin is not due to a direct effect of Ca2+ on the severing domain, but indirectly through an effect on domains in the COOH-terminal half of the molecule to allow exposure of both actin-binding sites.

PubMed Disclaimer

References

    1. J Biol Chem. 1984 Apr 25;259(8):5271-6 - PubMed
    1. J Biochem. 1984 Feb;95(2):377-85 - PubMed
    1. J Biol Chem. 1984 Jun 25;259(12):7480-7 - PubMed
    1. Biochemistry. 1984 Jun 19;23(13):3038-47 - PubMed
    1. J Biol Chem. 1984 Oct 10;259(19):11868-75 - PubMed

Publication types